Florence F Roussotte1, Prabha Siddarth2, David A Merrill2, Katherine L Narr3, Linda M Ercoli2, Jacqueline Martinez2, Natacha D Emerson2, Jorge R Barrio4, Gary W Small2. 1. Department of Neurology, Brain Mapping Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Electronic address: florence78@ucla.edu. 2. Department of Psychiatry & Biobehavioral Sciences, Semel Institute for Neuroscience & Human Behavior, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA. 3. Department of Neurology, Brain Mapping Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. 4. Department of Molecular & Medical Pharmacology, University of California, Los Angeles, CA, USA.
Abstract
OBJECTIVE: Growing evidence supports an association between increased blood pressure and: (a) poor cognitive performance in older adults, and (b) various biomarkers of increased Alzheimer's disease (AD) neuropathology. The objective of this study was to determine whether systolic blood pressure (SBP) and diastolic blood pressure (DBP) were significantly associated with cognitive functioning in non-demented adults, and to examine in vivo AD pathology as a possible mediator of this association. METHODS: Positron emission tomography (PET) scans with 2-(1-{6-[(2-[F-18]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile (FDDNP) provide in vivo measurements of plaque and tangle burden. A total of 101 non-demented older subjects with blood pressure data and FDDNP-PET scans were drawn from a larger study of predictors of cognitive decline. A neuropsychological test battery was used to compute "global cognitive scores" (averaged across five key domains), which served as an index of general cognitive functioning. RESULTS: Higher DBP (but not SBP) was significantly associated with lower cognitive scores, controlling for age, sex, antihypertensive medication use, and ApoE genotype (η2 = 0.06). However, this relationship was no longer significant after introducing FDDNP-PET binding as an additional covariate in the statistical models. In vivo plaque and tangle burden accounted for over 30% of the observed association between higher DBP and poorer cognitive performance. CONCLUSIONS: By suggesting a mediation of the relationship between DBP and cognitive functioning by FDDNP-PET binding, this study advances our understanding of some potential predictors of cognitive decline in non-demented adults, and underscores the importance of devising early multimodal interventions to more effectively combat degenerative brain disorders.
OBJECTIVE: Growing evidence supports an association between increased blood pressure and: (a) poor cognitive performance in older adults, and (b) various biomarkers of increased Alzheimer's disease (AD) neuropathology. The objective of this study was to determine whether systolic blood pressure (SBP) and diastolic blood pressure (DBP) were significantly associated with cognitive functioning in non-demented adults, and to examine in vivo AD pathology as a possible mediator of this association. METHODS: Positron emission tomography (PET) scans with 2-(1-{6-[(2-[F-18]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile (FDDNP) provide in vivo measurements of plaque and tangle burden. A total of 101 non-demented older subjects with blood pressure data and FDDNP-PET scans were drawn from a larger study of predictors of cognitive decline. A neuropsychological test battery was used to compute "global cognitive scores" (averaged across five key domains), which served as an index of general cognitive functioning. RESULTS: Higher DBP (but not SBP) was significantly associated with lower cognitive scores, controlling for age, sex, antihypertensive medication use, and ApoE genotype (η2 = 0.06). However, this relationship was no longer significant after introducing FDDNP-PET binding as an additional covariate in the statistical models. In vivo plaque and tangle burden accounted for over 30% of the observed association between higher DBP and poorer cognitive performance. CONCLUSIONS: By suggesting a mediation of the relationship between DBP and cognitive functioning by FDDNP-PET binding, this study advances our understanding of some potential predictors of cognitive decline in non-demented adults, and underscores the importance of devising early multimodal interventions to more effectively combat degenerative brain disorders.
Authors: Gary W Small; Vladimir Kepe; Linda M Ercoli; Prabha Siddarth; Susan Y Bookheimer; Karen J Miller; Helen Lavretsky; Alison C Burggren; Greg M Cole; Harry V Vinters; Paul M Thompson; S-C Huang; N Satyamurthy; Michael E Phelps; Jorge R Barrio Journal: N Engl J Med Date: 2006-12-21 Impact factor: 91.245
Authors: Jie Liu; Vladimir Kepe; Alenka Zabjek; Andrej Petric; Henry C Padgett; Nagichettiar Satyamurthy; Jorge R Barrio Journal: Mol Imaging Biol Date: 2007 Jan-Feb Impact factor: 3.488
Authors: Kooresh Shoghi-Jadid; Gary W Small; Eric D Agdeppa; Vladimir Kepe; Linda M Ercoli; Prabha Siddarth; Stephen Read; Nagichettiar Satyamurthy; Andrej Petric; Sung-Cheng Huang; Jorge R Barrio Journal: Am J Geriatr Psychiatry Date: 2002 Jan-Feb Impact factor: 4.105
Authors: Mi Ji Lee; Sang Won Seo; Duk L Na; Changsoo Kim; Jae Hyun Park; Geon Ha Kim; Chi Hun Kim; Young Noh; Hanna Cho; Hee Jin Kim; Cindy W Yoon; Byoung Seok Ye; Juhee Chin; Seun Jeon; Jong-Min Lee; Yearn Seong Choe; Kyung-Han Lee; Jae Seung Kim; Sung Tae Kim; Jae-Hong Lee; Michael Ewers; David J Werring; Michael W Weiner Journal: JAMA Psychiatry Date: 2014-04 Impact factor: 21.596
Authors: G Tsivgoulis; A V Alexandrov; V G Wadley; F W Unverzagt; R C P Go; C S Moy; B Kissela; G Howard Journal: Neurology Date: 2009-08-25 Impact factor: 9.910
Authors: Lojze M Smid; Vladimir Kepe; Harry V Vinters; Mara Bresjanac; Tatsushi Toyokuni; Nagichettiar Satyamurthy; Koon-Pong Wong; Sung-Cheng Huang; Daniel H S Silverman; Karen Miller; Gary W Small; Jorge R Barrio Journal: J Alzheimers Dis Date: 2013 Impact factor: 4.472
Authors: Hsu-Ko Kuo; Farzaneh Sorond; Ikechukwu Iloputaife; Margaret Gagnon; William Milberg; Lewis A Lipsitz Journal: J Gerontol A Biol Sci Med Sci Date: 2004-11 Impact factor: 6.053
Authors: Timothy M Hughes; Suzanne Craft; Laura D Baker; Mark A Espeland; Stephen R Rapp; Kaycee M Sink; Alain G Bertoni; Gregory L Burke; Rebecca F Gottesman; Erin D Michos; José A Luchsinger; Annette L Fitzpatrick; Kathleen M Hayden Journal: Alzheimers Dement (Amst) Date: 2017-03-31
Authors: Sander Lamballais; Ayesha Sajjad; Maarten J G Leening; Romy Gaillard; Oscar H Franco; Francesco U S Mattace-Raso; Vincent W V Jaddoe; Sabine J Roza; Henning Tiemeier; M Arfan Ikram Journal: J Am Heart Assoc Date: 2018-11-06 Impact factor: 5.501